Cargando…

Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19

BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varie...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmulson, M., Dávalos, M.F., Berumen, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158807/
https://www.ncbi.nlm.nih.gov/pubmed/32376072
http://dx.doi.org/10.1016/j.rgmx.2020.04.001
_version_ 1783522559378063360
author Schmulson, M.
Dávalos, M.F.
Berumen, J.
author_facet Schmulson, M.
Dávalos, M.F.
Berumen, J.
author_sort Schmulson, M.
collection PubMed
description BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varied from 3.0% to 39.6% and included diarrhea (7.5%), náusea (4.5%), anorexia (4.4%), vomiting (1.3%), abdominal pain (0.5%), and belching/reflux (0.3%). Those symptoms can be the first manifestation of COVID-19, but whether they reflect a better or worse prognosis, is controversial. The potential relation of the angiotensin converting enzyme 2 receptor in the digestive tract as an entry route for the virus is discussed. CONCLUSION: Gastrointestinal symptoms may be common in COVID-19, in some cases appearing as the first manifestation, even before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists must be aware of those atypical cases during the current pandemic, as well as of the fecal-oral route and corresponding preventive measures.
format Online
Article
Text
id pubmed-7158807
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A.
record_format MEDLINE/PubMed
spelling pubmed-71588072020-04-15 Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 Schmulson, M. Dávalos, M.F. Berumen, J. Rev Gastroenterol Mex Article BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varied from 3.0% to 39.6% and included diarrhea (7.5%), náusea (4.5%), anorexia (4.4%), vomiting (1.3%), abdominal pain (0.5%), and belching/reflux (0.3%). Those symptoms can be the first manifestation of COVID-19, but whether they reflect a better or worse prognosis, is controversial. The potential relation of the angiotensin converting enzyme 2 receptor in the digestive tract as an entry route for the virus is discussed. CONCLUSION: Gastrointestinal symptoms may be common in COVID-19, in some cases appearing as the first manifestation, even before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists must be aware of those atypical cases during the current pandemic, as well as of the fecal-oral route and corresponding preventive measures. Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. 2020 2020-04-15 /pmc/articles/PMC7158807/ /pubmed/32376072 http://dx.doi.org/10.1016/j.rgmx.2020.04.001 Text en © 2020 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Schmulson, M.
Dávalos, M.F.
Berumen, J.
Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
title Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
title_full Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
title_fullStr Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
title_full_unstemmed Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
title_short Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
title_sort alerta: los síntomas gastrointestinales podrían ser una manifestación de la covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158807/
https://www.ncbi.nlm.nih.gov/pubmed/32376072
http://dx.doi.org/10.1016/j.rgmx.2020.04.001
work_keys_str_mv AT schmulsonm alertalossintomasgastrointestinalespodrianserunamanifestaciondelacovid19
AT davalosmf alertalossintomasgastrointestinalespodrianserunamanifestaciondelacovid19
AT berumenj alertalossintomasgastrointestinalespodrianserunamanifestaciondelacovid19